Phase Forward (MM) News - PFWD | ADVFN

Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Phase Forward (MM) (PFWD)
Phase Forward (MM) (PFWD) News

Phase Forward (MM) (PFWD)

16.99

0.00

(0.00%)

Closed July 23 4:00PM

Delayed by 15 minutes

16.99

0.00

( 0.00% )

Pre Market: 8:00PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Cancer Research UK Standardizes on Phase Forward’s InForm™ Global Trial Management Solution

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today...

Phase Forward Appoints Michael Owings Chief Privacy Officer

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Phase Forward to Present at the 21st Annual Piper Jaffray Health Care Conference

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Phase Forward CFO Chris Menard to Present at 2009 MIT Sloan CFO Summit

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today...

- Quarterly Report (10-Q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q...

Phase Forward Named Private Sector Company of the Year by Mass Technology Leadership Council

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today...

Phase Forward Signs Multi-Year Agreement with Quotient Clinical for Use of InForm™ Electronic Data Capture Solution

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today...

Phase Forward Announces Share Repurchase Program

Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety...

Phase Forward to Present at the 18th Annual Credit Suisse Healthcare Conference

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today...

Phase Forward Teams with PharmaNet Development Group

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today...

Phase Forward to Participate in Six Industry Events in November

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, will...

Excelsior Mining

Delayed Upgrade Clock